CAMG
HRMY icon

CWA Asset Management Group’s Harmony Biosciences HRMY Stock Holding History

CWA Asset Management Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
61,273
+14,672
+31% +$463K 0.07% 259
2026
Q1 		$1.31M Buy
46,601
+6,484
+16% +$213K 0.04% 343
2025
Q4 		$1.5M Buy
40,117
+1,384
+4% +$45.5K 0.05% 287
2025
Q3 		$1.07M Buy
38,733
+9,514
+33% +$328K 0.04% 340
2025
Q2 		$923K Buy
29,219
+5,665
+24% +$182K 0.04% 340
2025
Q1 		$782K Buy
23,554
+5,275
+29% +$189K 0.04% 339
2024
Q4 		$629K Buy
18,279
+3,883
+27% +$133K 0.03% 345
2024
Q3 		$576K Buy
+14,396
New +$506K 0.03% 336

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CWA Asset Management Group's HRMY Position: Q2 2026 in Review

CWA Asset Management Group increased its Harmony Biosciences (HRMY) stake by 31% in Q2 2026, buying an estimated $463K and bringing the position to 61,273 shares worth $2.23M. The position accounts for 0.07% of the portfolio, ranked #259.

CWA Asset Management Group first reported a position in HRMY in Q3 2024 and has held it in 8 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • CWA Asset Management Group held 61,273 shares of Harmony Biosciences worth $2.23M as of Q2 2026.
  • CWA Asset Management Group bought 14,672 Harmony Biosciences shares in Q2 2026, an estimated $463K.
  • Harmony Biosciences made up 0.07% of CWA Asset Management Group's portfolio in Q2 2026, its #259 holding.
  • CWA Asset Management Group first reported a position in Harmony Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.